2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Large B-cell Lymphoma: new trials by email Literature Review of Large B-cell Lymphoma trials Research Report on Large B-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma CNCT19, Gemcitabine Injection, busulfan - Large B-cell Lymphoma | Phase 1 / Phase 2 | Completed | Institute of Hematology & Blood Diseases Hospital, China | 30 | 2021-01-01 | 2025-05-13 |
| Sequential CD19/CD22 CAR-T Cell Therapy Following ASCT Apheresis and Bridging Therapy, Conditioning and Stem Cell Transplantation, CAR-T Cell Administration - Large B-cell Lymphoma, CAR T Cell Therapy | Phase 2 | Completed | The First Affiliated Hospital of Soochow University | 23 | 2020-02-24 | 2025-11-19 |
Blood Component Removal (1) · Busulfan (1) · Gemcitabine (1) · Melphalan (1) · Stem Cell Transplantation (1)
Institute of Hematology & Blood Diseases Hospital, China (1) · The First Affiliated Hospital of Soochow University (1)
China (2)
Dehui Zou, Dr. (1)